Day: September 21, 2021

Clearside Biomedical Announces Completion of Dosing in Cohort 2 of Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMD Patients

ALPHARETTA, Ga., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments...

Izotropic Signs Agreement with Johns Hopkins University School of Medicine to Develop Deep Machine Learning Algorithms for IzoView Breast CT

Vancouver, British Columbia--(Newsfile Corp. - September 21, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing...

error: Content is protected !!